2002

Wyeth Pharmaceuticals Awards $73,000 in Scholarships to the Hemophilia Community

Wyeth Pharmaceuticals Introduces the First 2000 IU Vial of ReFacto^® for Hemophilia Treatment

Global Factor VIII Supply to Improve Following European Commission Approval, Release of Additional Supply

Hemophilia Solutions: An Update on Supply, January 2002

2001

New Wyeth Program Teaches Children About Hemophilia

Hemophilia Solutions: An Update on Supply, November 2001

Wyeth's Updated Web Site Goes Live

Sharing a Brighter Tomorrow: Wyeth Announces Soozie Courter Scholarship Winners

Wyeth Announces the Launch of ReFacto^® Antihemophilic Factor (Recombinant)

2000

Wyeth Launches "We Have Dreams" Corporate Campaign in Conjunction With National Hemophilia Foundation Annual Meeting

28-Year-Old With Hemophilia to Run in the Canadian International Marathon

Canadian Hemophilia Society Introduces "Care Until Cure" Research Program With Wyeth

The health information contained herein is provided for educational purposes only and is not meant to replace personal discussions between health care providers and patients. All decisions about patient care must be made with a health care provider who can assess the special needs of each individual patient.